Jump Financial, LLC Karyopharm Therapeutics Inc. Transaction History

Jump Financial, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$0.7 - $1.06 $18,758 - $28,405	-26,798 Closed	0 $0
Q2 2024 Aug 14, 2024	BUY	$0.87 - $1.58 $23,314 - $42,340	26,798 New	26,798 $23,000
Q4 2022 Feb 13, 2023	BUY	$2.48 - $5.93 $145,010 - $346,738	58,472 New	58,472 $198,000
Q2 2022 Aug 09, 2022	BUY	$4.15 - $8.37 $50,381 - $101,611	12,140 New	12,140 $54,000
Q1 2022 May 12, 2022	SELL	$5.91 - $14.38 $505,984 - $1.23 Million	-85,615 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$5.21 - $8.61 $446,054 - $737,145	85,615 New	85,615 $551,000
Q3 2021 Nov 12, 2021	SELL	$4.45 - $10.63 $312,768 - $747,129	-70,285 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$8.11 - $11.11 $63,136 - $86,491	7,785 Added 12.46%	70,285 $725,000
Q1 2021 May 17, 2021	BUY	$9.85 - $17.69 $615,625 - $1.11 Million	62,500 New	62,500 $658,000

57.6M

258K

81.2K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $55.9M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.